Role of IDO in Organ Transplantation: Promises and Difficulties
Authors:
- Stefan LöbSLStefan Löb
- Alfred KönigsrainerAKAlfred Königsrainer
- 1 January 2009
- journal article
- review article
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 28 (3-4) , 185-206
Abstract
Induction of donor-antigen-specific immunological tolerance still remains the "holy grail" in organ transplantation. Recently, Indoleamine-2,3 Dioxygenase (IDO)--a tryptophan degrading enzyme--has been shown to be implicated in one of nature's most impressive examples of tolerance, which is maternal acceptance of the semi-allogeneic foetus. Although many experimental findings propose IDO as a key player in induction and maintenance of peripheral tolerance, scepticism exists as to whether IDO represents a promising therapeutic target with clinical relevance. In this review article we will discuss the role of IDO in transplantation and take a critical look at IDO-based therapeutic strategies.Keywords
This publication has 112 references indexed in Scilit:
- SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesisProceedings of the National Academy of Sciences, 2008
- Cell Cycle Arrest by Kynurenine in Lens Epithelial CellsInvestigative Ophthalmology & Visual Science, 2008
- Exploring the mechanism of tryptophan 2,3-dioxygenaseBiochemical Society Transactions, 2008
- 3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosisProceedings of the National Academy of Sciences, 2007
- Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenaseJournal of Clinical Investigation, 2007
- CD40Ig treatment results in allograft acceptance mediated by CD8+CD45RClow T cells, IFN-γ, and indoleamine 2,3-dioxygenaseJournal of Clinical Investigation, 2007
- CTLA4Ig Promotes the Induction of Hematopoietic Chimerism and Tolerance Independently of Indoleamine-2,3-DioxygenaseTransplantation, 2007
- Long-term problems related to immunosuppressionTransplant Immunology, 2006
- AbataceptNature Reviews Drug Discovery, 2006
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003